🇺🇸 Latanoprost, 24-hour intraocular pressure monitoring in United States

Latanoprost, 24-hour intraocular pressure monitoring (Latanoprost, 24-hour intraocular pressure monitoring) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Latanoprost, 24-hour intraocular pressure monitoring in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Latanoprost, 24-hour intraocular pressure monitoring approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Latanoprost, 24-hour intraocular pressure monitoring in United States?

Aristotle University Of Thessaloniki is the originator. The local marketing authorisation holder may differ — check the official source linked above.